VOLUME 61   2000   NUMBER 9

Brainstorms

628 Paying Attention to Your Acetylcholine, Part 2: The Function of Nicotinic Receptors.
Stephen M. Stahl
[PDF]

Original Articles

630 The Implications of Genetic Studies of Major Mood Disorders for Clinical Practice. Anne Duffy,
Paul Grof, Carrie Robertson, and Martin Alda

[Abstract] [PDF]

638 A Naturalistic Comparison of Clozapine, Risperidone, and Olanzapine in the Treatment of Bipolar Disorder. Constance Guille, Gary S. Sachs, and S. Nassir Ghaemi
[Abstract] [PDF]

643 A Randomized, Double-Blind, Placebo-Controlled Trial of Moclobemide in Patients With Chronic Fatigue Syndrome. Ian B. Hickie, Andrew J. Wilson, J. Murray Wright, Barbara K. Bennett, Denis Wakefield, and Andrew R. Lloyd
[Abstract] [PDF]

649 Possible Induction of Mania and Hypomania by Olanzapine or Risperidone: A Critical Review of Reported Cases. Jean-Michel Aubry, Andor E. Simon, and Gilles Bertschy
[Abstract] [PDF]

656 Mirtazapine Compared With Paroxetine in Major Depression. Otto Benkert, Armin Szegedi, and Ralf Kohnen
[Abstract] [PDF]

664 Psychostimulant Augmentation During Treatment With Selective Serotonin Reuptake Inhibitors in Men With Paraphilias and Paraphilia-Related Disorders: A Case Series. Martin P. Kafka and John Hennen
[Abstract] [PDF]

671 Clinical and Psychopharmacologic Factors Influencing Family Burden in Refractory Schizophrenia. Robert Rosenheck, Joyce Cramer, George Jurgis, Deborah Perlick, Weichun Xu, Jonathan Thomas, William Henderson, and Dennis Charney, for the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
[Abstract] [PDF]

Academic Highlights

686 Novel Antidepressant Strategies to Optimize Outcome.
[PDF]

CME Article 697

698 Psychiatric Care of Patients With Depression and Comorbid Substance Use Disorders. Ivan D. Montoya, Dace Svikis, Steven C. Marcus, Ana Suarez, Terri Tanielian, and Harold Alan Pincus
[Abstract] [PDF]

Letters to the Editor

677 Association Between Premenstrual Syndrome and Depression. Claudio N. Soares and Lee S. Cohen
[PDF]

  • Reply by Catherine A. Roca, Peter J. Schmidt, and David R. Rubinow

678 Is Antipsychotic Drug-Induced Weight Gain Associated With a Favorable Clinical Response? J. Steven Lamberti
[PDF]

  • Reply by Rohan Ganguli

678 Polypharmacy of 2 Atypical Antipsychotics. Edward Rhoads
[PDF]

  • Reply by Stephen M. Stahl

680 Clarification of Anticholinergic Effects of Quetiapine. Jeffrey M. Goldstein and Martin Brecher
[PDF]

680 Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid. Joseph Levine, K. N. Roy Chengappa, and Haranath Parepally
[PDF]

681 Correction. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, and Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction (J Clin Psychiatry 2000;61:356-360)
[PDF]

Book Reviews 682

Information for authors

see July 2000, pages 542-544 or our Web site at www.psychiatrist.com/author.htm